Patent · US Active

Human plasma kallikrein inhibitors

US12162838B2 · kind B2 · utility

0Cited by
14References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2023
Grant dateDec 10, 2024
Priority date—
Expiry dateApr 18, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.